Ranked by engagement
Top topics — this year page 13
Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,076 topics · page 13 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
A calculator that gives a right answer to the wrong question — does this still hold?
A calculator that gives a right answer to the wrong question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand what…
|
+23 | 27 | 62k | 8mo |
|
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss, which is the part…
|
+22 | 26 | 57k | 5mo |
|
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
|
+58 | 64 | 9.7k | 2mo |
|
Revisiting: PCOS and metabolic overlap: what is and is not studied
Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
|
+55 | 59 | 26k | 2d |
|
Lipase elevation without symptoms: the interpretation problem
Lipase elevation without symptoms: the interpretation problem Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+21 | 25 | 62k | 5mo |
|
Pooling trials with different estimands — what changed since
Pooling trials with different estimands — what changed since — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURPASS-4 ( Lancet , 2021) and finding…
|
+57 | 64 | 12k | 7mo |
|
Revisiting: GLP-1 receptor distribution: central and peripheral
Revisiting: GLP-1 receptor distribution: central and peripheral — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+61 | 66 | 15k | 8mo |
|
Publishing an inconvenient result: a case study
On the subject in the title: Publishing an inconvenient result: a case study Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers asked for.…
|
+59 | 70 | 992 | 11mo |
|
Follow-up: How compounding permissions changed when supply normalised
How compounding permissions changed when supply normalised I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
+72 | 77 | 1.5k | 1d |
|
Coming back to: A structured critique template this community uses
Posting this under the heading it deserves: A structured critique template this community uses Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with SURMOUNT-1 ( N Engl J Med , 2022)…
|
+63 | 69 | 17k | 18h |
|
Tirzepatide molecular mass and the charge states you would expect on ESI
Tirzepatide molecular mass and the charge states you would expect on ESI Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited…
|
+36 | 40 | 44k | 11mo |
|
Sample handling between despatch and injection
Sample handling between despatch and injection Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the first three replies will…
|
+63 | 68 | 2.4k | 3mo |
|
The best-written scientific paper you have read
The best-written scientific paper you have read Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still applies if anyone makes a…
|
+69 | 74 | 1.1k | 2mo |
|
Request: export my own posts — one year on
Request: export my own posts — one year on — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
|
+66 | 70 | 14k | 4mo |
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+70 | 74 | 7k | 8mo |
|
What to include when your question involves a chromatogram — one year on
Asking directly, because I could not find a straight answer: What to include when your question involves a chromatogram — one year on Question in the title. Context below, and I have tried to include the…
|
+69 | 75 | 862 | 14d |
|
Revisiting: Mean kinetic temperature explained without the mathematics
Revisiting: Mean kinetic temperature explained without the mathematics Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I…
|
+67 | 75 | 909 | 2mo |
|
Where impurities in solid-phase peptide synthesis come from
Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a…
|
+54 | 59 | 14k | 3mo |
|
Pancreatitis history and the risk calculus
Posting this under the heading it deserves: Pancreatitis history and the risk calculus Everything below is what sits behind that. Asking about a population rather than about a person. The published trials in…
|
+28 | 32 | 52k | 17h |
|
What a regulator's shortage notice actually authorises — what changed since
The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…
|
+22 | 26 | 53k | 7mo |
|
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree
Detection wavelength and why 214 nm and 280 nm disagree — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies will…
|
+69 | 76 | 920 | 6h |
|
The headache that turns out to be dehydration — the long version
On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a…
|
+68 | 73 | 1.3k | 12h |
|
Does dual agonism explain the effect size, or is it dose?
Does dual agonism explain the effect size, or is it dose? I have a specific reason for asking rather than idle curiosity, and the context is below. Session topic: SURPASS-4 ( Lancet , 2021). Please read it…
|
+62 | 68 | 2.6k | 29d |
|
Enforcement priorities versus written rules — does this still hold?
Enforcement priorities versus written rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following…
|
+36 | 40 | 37k | 11mo |
|
Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. General question, not a request for advice about my own care — I…
|
+28 | 32 | 57k | 11mo |
|
Receptor desensitisation as a tolerance hypothesis, and its weak evidence
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+52 | 57 | 25k | just now |
|
Angle of injection and whether 90 degrees is always right — the long version
Angle of injection and whether 90 degrees is always right — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it,…
|
+50 | 55 | 15k | 2d |
|
Blinding yourself: practical methods and their limits
On the subject in the title: Blinding yourself: practical methods and their limits Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with STEP 4 ( JAMA , 2021) and finding the…
|
+40 | 44 | 33k | 5d |
|
Coming back to: Why most self-reports here are not experiments, and that is fine
The question in the title: Why most self-reports here are not experiments, and that is fine I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med , 2016) with…
|
+56 | 62 | 11k | 4mo |
|
Manufacturer assistance programmes and their eligibility rules
On the subject in the title: Manufacturer assistance programmes and their eligibility rules Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
|
+37 | 42 | 32k | 11d |